Cipla receives final USFDA approval for Efavirenz

Nikita Singh
/ Categories: Trending, Markets

Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).
 
Efavirenz tablets is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb’s Sustiva. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.
 
On Wednesday, the stock hit an intraday low of Rs. 606 per share and an intraday high of Rs. 622 per share on BSE. It had touched its 52-week low of Rs. 508 per share on May 26, 2017 and its 52-week high of Rs. 663 per share on November 7, 2017 on BSE, respectively.
 
At 1:24 hours IST, the stock was trading at Rs. 605.25 per share up by 0.44 per cent on BSE on Wednesday. The S&P BSE Sensex was trading at 35,521 level, up by 0.66 per cent and NSE Nifty50 trading at 10,769.35 level up by 0.55 per cent.

Rate this article:
4.3

Leave a comment

This form collects your name, email, IP address and content so that we can keep track of the comments placed on the website. For more info check our Privacy Policy and Terms Of Use where you will get more info on where, how and why we store your data.
Add comment

DSIJ MINDSHARE

Mkt Commentary31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Knowledge

General27-Jan, 2023

All About Fiscal Policy

All About Fiscal Policy

The United States government directs fiscal policy with the goal of maintaining a healthy economy.

General27-Jan, 2023

Explained: Monetary Policy in India

Explained: Monetary Policy in India

Monetary policy is the activities governed by the central bank that aim to influence the management of the...

General20-Jan, 2023

Cost of Capital Explained!

Cost of Capital Explained!

A business expands by making investments that are expected to increase revenue and profits. It obtains the...
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION